STAAR Surgical (STAA) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $0.25
- Estimate
- $0.23
- Surprise
- +9.7%
- Revenue (period 2026-07-03)
- $93.5M
- Score at report (before → after)
- 6.5 → 6.7/10
Revenue source: xbrl.
How the report landed
STAAR Surgical (STAA) beat the $0.23 estimate with adjusted EPS of $0.25 — a clear 9.7% upside surprise. TrendMatrix's engine moved from Buy (Wait) (6.5/10) to Hold at 6.7/10 after the report.
Coverage in the report window
- UBS Maintains Sell on Staar Surgical, Lowers Price Target to $19 — benzinga, 2026-08-13
Where TrendMatrix's rating stands now
TrendMatrix currently rates STAA Hold at 6.5/10.
3 of the last 4 quarters beat the estimate; this quarter's +9.7% surprise compares with a +62.4% four-quarter average. Next scheduled report: 2026-11-11.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Concentration risk — Geographic: outside the United States (91.0%)
- Concentration risk — Product: ICLs (100.0%)
- Thin upside margin: 10.0%
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $22.15
- Price target
- $24.36
- Stop
- $20.60
- Upside to target
- +10.0%
- Reward-to-risk
- 0.7:1
The stock trades at 276.9× trailing but 19.9× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-10-07 — shown for context, not personalized investment advice.
STAA at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $1.11B
- P/E (fwd)
- 19.9
- P/E (ttm)
- 276.9
- 52-week range
- $15.59–$35.87
- Off 52-week high
- 38.2%
- RSI (14)
- 48
- Volume vs avg
- 0.59×
- Score today
- 6.5/10